Prof. Andrew Shaw
CEO & Founder
Attomarker is Prof Shaw’s second spinout company, the first having been sold for $8M. He will move to Chief Scientist when the next round is closed.
Dr Jonathan Snicker
Executive Chair and Chief Strategy Officer
20+ years’ experience in variety of Board and Executive roles spanning, business development, philanthropy, university academia, strategic, political, comms and funding advisory.
Sakura Holloway
NED, BIF Opportunities LP
Sakura represents Future Planet Capital as Portfolio Manager for their BIF Opportunities Fund, a specialist Life Sciences and AgTech venture capital fund investing in UK university spinouts at Series A/B stage.
Sandy Primrose
NED
Experienced Biotech entrepreneur as Chair and Director for many companies leading to trade sales
Yves Le Goff
Strategic Adviser and CCO, EU Markets
Yves co-led Attomarker’s GBP1.5m Future Fund 2020 funding round. He is a former investment banker (Goldman Sachs, Credit Suisse) and early-stage investor
Robert Warner
CFO
Chartered Accountant from KPMG, with 20 years’ experience as a commercial CFO, gained across a variety of rapid-scale international businesses in diverse sectors
Chandru R. Chandrasekar
Director of International Development
Chandru is an investor and former orthopaedic surgeon with deep connections in India and Singapore, with a mission to nurture sustainable technology platforms at ‘India Scale, India Price’.
Steve Brine
Advisor
Former MP, Health Minister and Chair of the cross-party Commons Health Select Committee, Steve is an authoritative voice on public health, healthcare innovation, and the prevention of ill health.
Dr Shivali Kohli
Director of Products
With a PhD in neuropharmacology and 10+ years in scientific research at leading universities, she brings a wealth of experience in project and team management.
Dr Philip James-Pemberton
Director of Research
Philip James-Pemberton leads the development of innovative diagnostic technologies. With a background in biomedical research and extensive experience in nanophotonic testing, he specialises in translating cutting-edge science into practical healthcare solutions. Philip plays a key role in advancing rapid, precise diagnostics for real-world applications.
